These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9379447)

  • 1. Angiotensin analogues palmitoylated in positions 1 and 4.
    Maletínská L; Neugebauer W; Pérodin J; Lefebvre M; Escher E
    J Med Chem; 1997 Sep; 40(20):3271-9. PubMed ID: 9379447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin antagonists and the adrenal cortex and medulla.
    Peach MJ; Ackerly JA
    Fed Proc; 1976 Nov; 35(13):2502-7. PubMed ID: 976492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
    Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
    J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.
    Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D
    J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
    Goghari MH; Franklin KJ; Moore GJ
    J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
    Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
    J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade.
    Moore GJ; Ganter RC; Goghari MH; Franklin KJ
    Int J Pept Protein Res; 1991 Jul; 38(1):1-7. PubMed ID: 1938100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and AT2 receptor-binding properties of angiotensin II analogues.
    Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Hallberg A; Karlén A
    J Pept Res; 2004 Nov; 64(5):194-201. PubMed ID: 15485557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupole.
    Moore GJ; Ganter RC; Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Wilkinson S; Sandall J; Fowler P
    J Mol Recognit; 1994 Dec; 7(4):251-6. PubMed ID: 7734150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation in positions 1 and 7 of angiotensin II. A structure-activity relationship study.
    Cordopatis P; Manessi-Zoupa E; Theodoropoulos D; Bossé R; Bouley R; Gagnon S; Escher E
    Int J Pept Protein Res; 1994 Oct; 44(4):320-4. PubMed ID: 7875933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive binding activity of angiotensin II analogues in an adrenal cortex radioligand-receptor assay;
    Saltman S; Baukal A; Waters S; Bumpus FM; Catt KJ
    Endocrinology; 1975 Aug; 97(2):275-82. PubMed ID: 169121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Active metabolites derived from angiotensin II].
    Chansel D; Ardaillou R
    Nephrologie; 1998; 19(7):427-32. PubMed ID: 9857379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An angiotensin II antagonist with strongly prolonged action.
    Holck M; Bossé R; Fischli W; Gerold H; Escher E
    Biochem Biophys Res Commun; 1989 May; 160(3):1350-6. PubMed ID: 2730646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II analogues with sulphur-containing side-chains in position 5. A structure-activity relationship study.
    Pérodin J; Bouley R; Escher E; Assimomytis N; Magafa V; Manessi-Zoupa E; Theodoropoulos D; Cordopatis P
    Arzneimittelforschung; 2000 Jun; 50(6):526-9. PubMed ID: 10918944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An angiotensin with prolonged action and blood pressure--lowering properties.
    Bossé R; Gerold M; Fischli W; Holck M; Escher E
    J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S50-5. PubMed ID: 1705628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of position 4 in angiotensin II antagonism: a structure-activity study.
    Samanen J; Cash T; Narindray D; Brandeis E; Yellin T; Regoli D
    J Med Chem; 1989 Jun; 32(6):1366-70. PubMed ID: 2724307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
    Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
    J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.
    Smith DD; Saha S; Fang G; Schaffert C; Waugh DJ; Zeng W; Toth G; Hulce M; Abel PW
    J Med Chem; 2003 Jun; 46(12):2427-35. PubMed ID: 12773046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular angiotensin II receptor and calcium signaling in toadfish.
    Qin ZL; Yan HQ; Nishimura H
    Gen Comp Endocrinol; 1999 Jul; 115(1):122-31. PubMed ID: 10375471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contractile effects of angiotensin peptides in rat aorta are differentially dependent on tyrosine kinase activity.
    Petrescu G; Costuleanu M; Slatineanu SM; Costuleanu N; Foia L; Costuleanu A
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):180-7. PubMed ID: 11881120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.